PostEra
Boston
About PostEra
PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and helped lead the world's largest open-science drug discovery effort; COVID Moonshot.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.4M
- Funding stage: Early Stage Venture
- Last round: Grant (May 2022)
- Website: postera.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/postera-86936 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.